The Decrease in Healthcare‐Associated Methicillin‐Resistant Staphylococcus aureus Infections and Savings From Glycopeptide Use

• Published in: Infection control and hospital epidemiology Vol. 27; no. 10; pp. 1131 - 1132
• Main Authors: COSKUN, Diler, AYTAC, Jale
• Format: Journal Article
• Language: English
• Published: Thorofare, NJ The University of Chicago Press 01-10-2006; Slack
• Subjects: Antibacterial agents; Antibiotics; Antibiotics. Antiinfectious agents. Antiparasitic agents; Bacterial diseases; Biological and medical sciences; Concise Communication; Cross Infection - drug therapy; Cross Infection - epidemiology; Dosage; Glycopeptides; Glycopeptides - economics; Glycopeptides - therapeutic use; Hospitals; Human bacterial diseases; Humans; Infection control; Infections; Infectious diseases; Medical sciences; Methicillin Resistance; Miscellaneous; Morbidity; Nursing; Ointments; Pharmacology. Drug treatments; Public health. Hygiene; Public health. Hygiene-occupational medicine; Staphylococcal Infections - drug therapy; Staphylococcal Infections - epidemiology; Staphylococcal infections, streptococcal infections, pneumococcal infections; Staphylococcus aureus; Turkey - epidemiology; Turkey; Infection; Peptides; Glycopeptide; Bacteriosis; Bacteria; Micrococcales; Micrococcaceae; Staphylococcal infection; Public health; Staphylococcus aureus
• ISSN: 0899-823X; 1559-6834
• DOI: 10.1086/507969

We evaluated changes in the rate of healthcare‐associated methicillin‐resistant Staphylococcus aureus (MRSA) infections and healthcare‐associated S. aureus infections after implementation of infection control precautions and the effect of this on glycopeptide use and expenditures for glycopeptides in a private medical center in Turkey in the years 2000‐2005. A striking decrease was obtained in the number of MRSA infections, and the expenditure for glycopeptide use also decreased.